ES495137A0 - Un procedimiento para la preparacion de derivados de cefalosporina. - Google Patents

Un procedimiento para la preparacion de derivados de cefalosporina.

Info

Publication number
ES495137A0
ES495137A0 ES495137A ES495137A ES495137A0 ES 495137 A0 ES495137 A0 ES 495137A0 ES 495137 A ES495137 A ES 495137A ES 495137 A ES495137 A ES 495137A ES 495137 A0 ES495137 A0 ES 495137A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES495137A
Other languages
English (en)
Other versions
ES8200113A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of ES495137A0 publication Critical patent/ES495137A0/es
Publication of ES8200113A1 publication Critical patent/ES8200113A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES495137A 1979-09-18 1980-09-17 Un procedimiento para la preparacion de derivados de cefalosporina. Expired ES8200113A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11878879A JPS5643288A (en) 1979-09-18 1979-09-18 Cephalosporin derivative and its preparation

Publications (2)

Publication Number Publication Date
ES495137A0 true ES495137A0 (es) 1981-10-16
ES8200113A1 ES8200113A1 (es) 1981-10-16

Family

ID=14745096

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495137A Expired ES8200113A1 (es) 1979-09-18 1980-09-17 Un procedimiento para la preparacion de derivados de cefalosporina.

Country Status (10)

Country Link
US (1) US4393058A (es)
JP (1) JPS5643288A (es)
AR (2) AR227398A1 (es)
BE (1) BE885265A (es)
CA (1) CA1148142A (es)
DE (1) DE3035259C2 (es)
ES (1) ES8200113A1 (es)
FR (1) FR2465739A1 (es)
GB (1) GB2058769B (es)
IT (1) IT1145390B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758557A (en) * 1985-06-26 1988-07-19 Meiji Seika Kaisha, Ltd. Cephalosporin derivatives and bactericides containing the same
US5254571A (en) * 1988-04-21 1993-10-19 Smith Kline & French Laboratories Ltd. Chemical compounds
DE19500760A1 (de) * 1995-01-13 1996-07-18 Basf Ag Substituierte 2-Phenylpyridine
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
JP4046708B2 (ja) * 2004-06-04 2008-02-13 明治製菓株式会社 3−アルケニルセフェム化合物の製造方法
CN103889223A (zh) 2011-08-29 2014-06-25 Ptc医疗公司 抗细菌化合物及其使用方法
WO2013033258A1 (en) 2011-08-29 2013-03-07 Ptc Therapeutics, Inc. Antibacterial compounds and methods for use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS551273B2 (es) * 1972-12-21 1980-01-12
CA1074784A (en) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
JPS5293790A (en) * 1976-02-02 1977-08-06 Sumitomo Chem Co Ltd 7-(n-acylamino-alpha-arylacetamide) cephalosporins
US4302454A (en) * 1976-03-03 1981-11-24 Sumitomo Chemical Company, Limited Cephalosporins
JPS5344585A (en) * 1976-10-02 1978-04-21 Meiji Seika Kaisha Ltd Cephalosporin derivatives and their preparation
DE2658905A1 (de) * 1976-12-24 1978-10-19 Bayer Ag Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4101661A (en) * 1977-06-03 1978-07-18 Warner-Lambert Novel antibacterial amide compounds and process means for producing the same
DE2924948A1 (de) * 1979-06-21 1981-01-22 Thomae Gmbh Dr K Neue cephalosporine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPS5643288A (en) 1981-04-21
IT1145390B (it) 1986-11-05
US4393058A (en) 1983-07-12
DE3035259A1 (de) 1981-03-19
FR2465739A1 (fr) 1981-03-27
AR227398A1 (es) 1982-10-29
AR227452A1 (es) 1982-10-29
GB2058769A (en) 1981-04-15
CA1148142A (en) 1983-06-14
IT8049684A0 (it) 1980-09-17
ES8200113A1 (es) 1981-10-16
DE3035259C2 (de) 1986-03-13
BE885265A (fr) 1981-01-16
GB2058769B (en) 1984-04-18
FR2465739B1 (es) 1983-06-17

Similar Documents

Publication Publication Date Title
ES497304A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilamino-fluorano.
ES514993A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES487843A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES497640A0 (es) Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina
ES488886A0 (es) Un procedimiento para la preparacion de derivados acidos penemcarboxilicos.
ES520983A0 (es) Un procedimiento para preparacion de nuevos derivados de cefalosporina.
ES495586A0 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
ES501805A0 (es) Un procedimiento para la preparacion de derivados de la eta-nolamina
ES495163A0 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES493579A0 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES490510A0 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES490722A0 (es) Un procedimiento para la preparacion de nuevos derivados de piridazina.
ES507997A0 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ES495589A0 (es) Un procedimiento para la preparacion de derivados de imida- lol.
ES494237A0 (es) Un procedimiento para la preparacion de derivados de 2-aminopirimidina.
ES495932A0 (es) Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.
ES495865A0 (es) Un procedimiento para la preparacion de derivados de quina- zolina
ES494130A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoxocina.
ES495137A0 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
ES488847A0 (es) Un procedimiento para la preparacion de un antibiotico de cefalosporina.
ES490289A0 (es) Un procedimiento para la preparacion de derivados de xantina
ES500381A0 (es) Un procedimiento para la preparacion de derivados de pirro- lidina
ES488231A0 (es) Un procedimiento para la preparacion de derivados de penici-lina o de cefalosporina
AR222208A1 (es) Un procedimiento para la preparacion de derivados de 4-amino-2-piperidino-quinazolina
ES490011A0 (es) Un procedimiento para la preparacion de derivados de 2-epi- fortimicina.